UPDATE : Wednesday, August 5, 2020
‘Korea still slow to expand benefit for new drugs’
Avi Ben-Shoshan, chairman of the Korea Research-based Pharma Industry Assoc...
by Kim Yun-mi  |  2019-12-24 15:37
Shanghai Ocumension to market Huonland's HA eyedrop
Huonland, a joint venture between Huons and Beijing Northland, said that it...
by Lee Han-soo  |  2019-12-23 15:43
Alteogen's growth hormone deficiency treatment wins orphan drug status
Alteogen said that the U.S. Food and Drug Administration has granted an orp...
by Lee Han-soo  |  2019-12-23 14:46
Daewoong partners with Aeon Biopharma to tap therapeutic BTX market
Daewoong Pharmaceutical said that it has agreed with Aeon Biopharma to expa...
by Lee Han-soo  |  2019-12-23 11:23
Successful drug development – getting it right from the start
When it comes to successful drug development, today’s pharma and biotech co...
by Lee Han-soo  |  2019-12-20 16:30
Pfizer wins Champix patent suit against 20 local generics makers
Pfizer won a patent lawsuit against local drugmakers over its antismoking d...
by Jeong Sae-im  |  2019-12-20 16:28
Chemas to research anticancer treatment in Germany
Chemas, a local pharmaceutical company, said that it has completed its prep...
by Lee Han-soo  |  2019-12-20 15:18
Bridge Biotherapeutics seeks IND status for lung cancer treatment
Bridge Biotherapeutics said it has filed an investigational new drug (IND) ...
by Lee Han-soo  |  2019-12-20 14:41
Boehringer Ingelheim stops developing Pharmaxis’ NASH treatment candidate
Boehringer Ingelheim said that it has decided to discontinue its developmen...
by Lee Han-soo  |  2019-12-19 17:42
AstraZeneca, Korean partners launch joint project to accelerate bio-health innovation
AstraZeneca said that it has signed a memorandum of understanding with four...
by Lee Han-soo  |  2019-12-19 17:40
AstraZeneca, SK Holdings celebrates manufacturing partnership
AstraZeneca and SK Holdings said they have reached an important milestone i...
by Lee Han-soo  |  2019-12-19 16:39
Daewoong wins sales approval for Nabota in UAE, Indonesia
Daewoong Pharmaceutical said that it has received sales approval for its bo...
by Lee Han-soo  |  2019-12-19 12:09
Crystal Genomics acquires Hwail as subsidiary
Crystal Genomics said that it has acquired Hwail Pharmaceutical as its subs...
by Lee Han-soo  |  2019-12-18 17:48
4 new botulinum toxins to undergo trials in crowded market
Small and mid-size domestic companies are rushing to develop botulinum toxi...
by Jeong Sae-im  |  2019-12-18 15:29
‘Roche's Xofluza to revolutionize influenza antivirals’
Roche Korea’s Xofluza is a new influenza treatment, a first-in-class, singl...
by Lee Han-soo  |  2019-12-17 16:30
Novartis reaffirms efficacy of Tasigna in treating chronic myelogenous leukemia
Novartis Korea said that it has affirmed the efficacy of Tasigna, a chronic...
by Lee Han-soo  |  2019-12-17 14:48
CDK4/6+fulvestrant combo may get benefit in 1st half of 2020
The combination therapy of cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor ...
by Kim Yun-mi  |  2019-12-17 11:59
CJ Healthcare unites with Standigm to develop AI-based anticancer drugs
CJ Healthcare said that it plans to develop new anticancer drugs jointly wi...
by Lee Han-soo  |  2019-12-17 11:58
Dong-A, Meiji Seika to conduct P1 trial for Stelara biosimilar
Dong-A Socio Holdings and Meiji Seika Pharmaceutical said they have started...
by Lee Han-soo  |  2019-12-16 17:01
Huons Lab, Pangen to codevelop human genetic recombinant hyaluronidase
Huons Lab, a subsidiary of Huons, said that it would cooperate in developin...
by Lee Han-soo  |  2019-12-16 15:23
Back to Top